Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study
Authors:
- Smeeta JobanputraSJSmeeta Jobanputra
- Meera KatariaMKMeera Kataria
- Bilgin GuratesBGBilgin Gurates
- Serdar E BulunSBSerdar E Bulun
- 1 February 2004
- journal article
- clinical trial
- Published by Elsevier in Fertility and Sterility
- Vol. 81 (2) , 290-296
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The Essential Role of the Aromatase/P450aromSeminars in Reproductive Medicine, 2002
- Prolonged GnRH agonist and add-back therapy for symptomatic endometriosis: long-term follow-up*1Obstetrics & Gynecology, 2002
- Aromatase Inhibitors in the Treatment and Prevention of Breast CancerJournal of Clinical Oncology, 2001
- Long-term use of gonadotropin-releasing hormone analogs and hormone replacement therapy in the management of endometriosis: a randomized trial with a 6-year follow-upFertility and Sterility, 2000
- Gonadotropin-releasing hormone agonist plus “add-back” hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trialFertility and Sterility, 2000
- Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic targetFertility and Sterility, 1999
- Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis.Endocrine-Related Cancer, 1999
- The evidence for the management of endometriosisCurrent Opinion in Obstetrics and Gynecology, 1998
- Treatment of Severe Postmenopausal Endometriosis With an Aromatase InhibitorFertility and Sterility, 1998
- Progestins for symptomatic endometriosis: a critical analysis of the evidenceFertility and Sterility, 1997